1. Mitigations in Selected Haemostatic Parameters in Administration of Graded Doses of Dexamethasone and its Blockers in Wister Rats
- Author
-
Odigie Om and Nwangwa Ek
- Subjects
Vitamin ,medicine.medical_specialty ,medicine.diagnostic_test ,medicine.drug_class ,business.industry ,Vitamin E ,medicine.medical_treatment ,General Medicine ,Fibrinogen ,chemistry.chemical_compound ,Endocrinology ,chemistry ,Clotting time ,Bleeding time ,Internal medicine ,polycyclic compounds ,medicine ,Corticosteroid ,Platelet ,business ,hormones, hormone substitutes, and hormone antagonists ,Dexamethasone ,medicine.drug - Abstract
Clinical trials have shown that an even newer compound, dexamethasone (Dex), might be more potent and less likely to cause side-effects than any other known corticosteroid medication. This study investigated the possible changes in selected haemostatic parameters [clotting time, bleeding time, platelets count and fibrinogen level] in albino wistar rats, following administration of graded doses of Dex. Forty-two male albino Wistar rats were randomly grouped into seven of six rats each. With Group A receiving normal diets (Control), Groups B-G were respectively given 0.1 mg/Kg of Dex, 0.3 mg/Kg of Dex, 0.1 mg/Kg of Dex +33 mg/Kg of Ketokonazol (Keto), 0.3 mg/Kg of Dex +33 mg/Kg of Keto, 0.1 mg/Kg of Dex+Vitamin (Vit) E and 0.1 mg/Kg of Dex. +Vit E. following two-weeks administration period, rats were euthanized and blood samples obtained by cardiac puncture under diethyl ether to determine haemostatic parameters. One-way Analysis of Variance (ANOVA) revealed that Dex, in higher doses decreased bleeding and clotting time, with significant increase (p
- Published
- 2018
- Full Text
- View/download PDF